| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.30▼ | 0.30▲ | 0.30▲ | 0.28▲ | 0.28▲ |
| MA10 | 0.30▲ | 0.30▲ | 0.30▲ | 0.27▲ | 0.27▲ |
| MA20 | 0.30▲ | 0.30▲ | 0.29▲ | 0.27▲ | 0.29▲ |
| MA50 | 0.29▲ | 0.28▲ | 0.27▲ | 0.27▲ | 0.33▼ |
| MA100 | 0.28▲ | 0.28▲ | 0.28▲ | 0.29▲ | 0.35▼ |
| MA200 | 0.28▲ | 0.27▲ | 0.28▲ | 0.34▼ | 0.37▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▲ | -0.001▼ | 0.000▼ | 0.004▲ | 0.002▲ |
| RSI | 55.064▲ | 58.102▲ | 59.857▲ | 63.139▲ | 49.669▼ |
| STOCH | 84.330▲ | 53.867 | 34.915 | 60.597 | 49.063 |
| WILL %R | -29.915 | -51.163 | -45.455 | -24.242▲ | -25.000 |
| CCI | 58.196 | 28.689 | 29.545 | 178.496▲ | 65.008 |
|
Wednesday, April 08, 2026 10:02 AM
POTOMAC, MD / ACCESS Newswire / April 8, 2026 /IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company"), a clinical-stage biotechnology company with its lead program currently in a Phase 2 CALMA ...
|
|
Wednesday, April 08, 2026 09:13 AM
IGC Pharma Inc. research and ratings by Barron's. View IGC revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.
|
|
Tuesday, April 07, 2026 05:28 AM
POTOMAC, MD / ACCESS Newswire / April 7, 2026 /IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company"), a clinical-stage biotechnology company developing innovative treatments for Alzheimer's ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 10/04/26 | 0.2916 | 0.3035 | 0.2916 | 0.30 | 405,359 |
| 09/04/26 | 0.28 | 0.316 | 0.28 | 0.301 | 1,263,380 |
| 08/04/26 | 0.2789 | 0.293 | 0.26 | 0.28 | 717,401 |
| 07/04/26 | 0.2668 | 0.2757 | 0.2668 | 0.2705 | 117,241 |
| 06/04/26 | 0.2666 | 0.2769 | 0.2614 | 0.2681 | 350,789 |
| 02/04/26 | 0.27 | 0.27 | 0.2591 | 0.2651 | 84,875 |
| 01/04/26 | 0.2622 | 0.2868 | 0.2575 | 0.2714 | 235,260 |
| 31/03/26 | 0.255 | 0.2669 | 0.255 | 0.263 | 156,026 |
| 30/03/26 | 0.268 | 0.268 | 0.2516 | 0.2555 | 135,955 |
| 27/03/26 | 0.267 | 0.267 | 0.252 | 0.2553 | 275,872 |
|
|
||||
|
|
||||
|
|